Novartis secures victory as MS drug patent is upheld

18-08-2020

Muireann Bolger

Novartis secures victory as MS drug patent is upheld

In a win for Novartis Pharmaceuticals, the US District Court for the district of Delaware has upheld the patent on its top-selling multiple sclerosis drug Gilenya.


Novartis, victory, drug, patent, generic, Gilenya, multiple sclerosis, block, Apotex

LSIPR